Join us for this exciting new lecture series featuring UW researchers, covering topics from testing and response measures to vaccine development and social & economic impacts.

The COVID-19 crisis has brought a whirlwind of changes that have impacted everyone in our community — including this year’s graduating class of medical students at UW School of Medicine. 

In the last few weeks, the students were pulled from their clinical rotations early.

Then, the difficult and unprecedented decision was made to hold the School’s Match Day ceremony online.

Paul Drain—an Associate Professor in the Department of Global Health, Medicine and Epidemiology at the University of Washington—and his research team have received a new grant from the CoMotion Innovation Gap Fund, a program intended to help bridge the gap between academic research grants and the level of development needed to obtain investment. Drain’s project is titled “Rapid test for measuring adherence to antiretroviral therapy and pre-exposure prophylaxis”.  

The University of Washington/Fred Hutch Center for AIDS Research (CFAR) recently announced the recipients of their International Infrastructure Awards. Geoffrey Gottlieb, and Adjunct Professor of Global Health, and John Kinuthia, an Affiliate Associate Professor, each received awards.

This message was sent to students on all University of Washington campuses.

Dear Students,

Today we are announcing our path forward for spring quarter 2020. Thank you, again, for your perseverance and goodwill as we navigate difficult, uncertain and rapidly changing times in our country and the world.

Classes and instruction to be offered remotely throughout spring quarter

A University of Washington study provides some of the first details of 21 critically ill patients with the coronavirus disease 2019 (COVID-19) in the United States, most of whom were linked to exposures at a nursing home at the center of the country’s COVID-19 outbreak early on in the global crisis.

Newly reported research findings may help in detecting and preventing the spread of COVID19 at independent and assisted living community for senior adults.

One of the valuable lessons from the study at an affected retirement center in Seattle:  Health-professionals should not rely solely on symptoms to determine if an older adult should receive a lab test for the coronavirus.

Updated: April 6, 2020 at 8:34 p.m.

The benefits of hydroxychloroquine being investigated in multi-site clinical trial launching in April

Researchers are investigating whether hydroxychloroquine – a commonly used anti-malarial and autoimmune drug – can prevent COVID-19.

A multi-site clinical trial, led by the University of Washington Department of Global Health/International Clinical Research Center (ICRC)  in collaboration with NYU Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.

In a forecast based on new data analyses, researchers find demand for ventilators and beds in US hospital intensive care units (ICUs) will far exceed capacity for COVID-19 patients as early as the second week of April. Deaths related to the current wave of COVID-19 in the US are likely to persist into July, even assuming people protect themselves and their communities by strongly adhering to social distancing measures and by taking other precautions advised by public health officials.